PREDICTORS AND OUTCOMES OF STEROID-REFRACTORY IMMUNE CHECKPOINT INHIBITOR HEPATITIS

被引：0
|
作者：
Li, Michael [1 ]
Sack, Jordan [1 ]
Rahma, Osama E. [2 ]
Grover, Shilpa [1 ]
Zucker, Stephen D. [1 ]
机构：
[1] Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA
来源：
HEPATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
115
引用
收藏
页码：85A / 85A
页数：1
相关论文
共 50 条
  • [31] Original Research Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncology
    Alouani, Emily
    Laparra, Ariane
    Perret, Audrey
    Sakkal, Madonna
    Messayke, Sabine
    Danlos, Francois-Xavier
    Ouali, Kaissa
    Hollebecque, Antoine
    Even, Caroline
    Ammari, Samy
    Baldini, Capucine
    Champiat, Stephane
    Besse, Benjamin
    Robert, Caroline
    Guettier, Catherine
    Samuel, Didier
    Lambotte, Olivier
    De Martin, Eleonora
    Michot, Jean-Marie
    [J]. EUROPEAN JOURNAL OF CANCER, 2023, 193
  • [32] Vedolizumab for steroid & infliximab refractory immune checkpoint inhibitor associated colitis
    Klemm, Natasha
    Trasolini, Roberto
    Chahal, Daljeet
    Donnellan, Fergal
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (04)
  • [33] Case Report: Successful Treatment of Steroid-Refractory Immune Checkpoint Inhibitor-Related Pure Red Cell Aplasia With Cyclosporin
    Gerard, Alexandre
    Romani, Serena
    Van-Obberghen, Elise
    Fresse, Audrey
    Muzzone, Marine
    Parassol, Nadege
    Boscagli, Annick
    Rocher, Fanny
    Borchiellini, Delphine
    Drici, Milou-Daniel
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [34] Success and failure of additional immunosuppressants in steroid-refractory pneumonitis related to immune checkpoint blockade.
    Beattie, Jason
    Fuentes, Paige
    Rizvi, Hira
    Luo, Jia
    Schoenfeld, Adam Jacob
    Postow, Michael A.
    Callahan, Margaret K.
    Warner, Allison Betof
    Chawla, Mohit
    Hellmann, Matthew David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [35] Outcomes and Predictors of Response in Steroid-Refractory Acute Graft-versus-Host Disease
    Rashidi, Armin
    DeFor, Todd E.
    Holtan, Shernan G.
    Blazar, Bruce R.
    Weisdorf, Daniel J.
    MacMillan, Margaret L.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (11) : 2297 - 2302
  • [36] Treatment of steroid-refractory autoimmune arthritis induced by immune checkpoint inhibitor therapy with the anti-interleukin-17-A/F antibody bimekizumab
    Springer, R.
    Lange, K. E.
    Lindhof, H. H.
    Meller, S.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 134 - 135
  • [37] Steroid-refractory immune related hepatitis may hide viral re-activation
    Citarella, Fabrizio
    Galletti, Alessandro
    Russano, Marco
    Gallo, Paolo
    Vespasiani-Gentilucci, Umberto
    Picardi, Antonio
    Tonini, Giuseppe
    Vincenzi, Bruno
    Santini, Daniele
    [J]. FUTURE SCIENCE OA, 2020, 6 (09):
  • [38] Successful Treatment of Steroid-Refractory Immune Thrombocytopenia in a Patient Developing Multiple Myeloma While on Immune Checkpoint Inhibitor Therapy for Lung Cancer: A Case Report
    Hayashi, Yudai
    Tsukada, Masao
    Shinoda, Daisuke
    Matsui, Marina
    Iwama, Kanichi
    Kajiwara, Koichi
    Yasuji, Kozai
    [J]. JOURNAL OF BLOOD MEDICINE, 2024, 15
  • [39] Infliximab in the treatment of tislelizumab-induced steroid-refractory immune checkpoint inhibitor-related pneumonia: case report and literature review
    Chen, Zhujun
    He, Jian
    [J]. TRANSLATIONAL CANCER RESEARCH, 2022, 11 (09) : 3309 - 3314
  • [40] Successful treatment of steroid-refractory immune thrombocytopenia with alemtuzumab
    Jung, Chul Won
    Cho, Su-Hee
    Park, Sylvia
    Jang, Jun Ho
    Ji, Jun Ho
    [J]. BLOOD RESEARCH, 2016, 51 (04) : 297 - 299
12345